The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of the combination of lurbinectedin and atezolizumab in a humanized mouse model.
 
Eugenio Bustos Morán
Employment - PharmaMar
Stock and Other Ownership Interests - PharmaMar
Travel, Accommodations, Expenses - PharmaMar
 
Daniel Torralba
Employment - PharmaMar
Stock and Other Ownership Interests - PharmaMar
Travel, Accommodations, Expenses - PharmaMar
 
Ismael Fernandez Miranda
Employment - PharmaMar
Stock and Other Ownership Interests - PharmaMar
Travel, Accommodations, Expenses - PharmaMar
 
Maria Jose Guillen
Employment - PharmaMar
Stock and Other Ownership Interests - PharmaMar
Patents, Royalties, Other Intellectual Property - PharmaMar
Travel, Accommodations, Expenses - PharmaMar
 
Marcelo Ribeiro
Employment - PharmaMar
Stock and Other Ownership Interests - PharmaMar
 
Pablo Aviles
Employment - PharmaMar
Stock and Other Ownership Interests - PharmaMar
Patents, Royalties, Other Intellectual Property - PharmaMar
Travel, Accommodations, Expenses - PharmaMar
 
Carmen Cuevas
Employment - PharmaMar
Leadership - PharmaMar
Stock and Other Ownership Interests - PharmaMar
Patents, Royalties, Other Intellectual Property - PharmaMar
Travel, Accommodations, Expenses - PharmaMar
 
Antonio Calles
Honoraria - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck KGaA; Merck Sharp & Dohme; Novartis; Pfizer; PharmaMar; Roche/Genentech; Sanofi/Regeneron; Takeda
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; IGEN BIOTECH; Johnson & Johnson/Janssen; Lilly; Merck Serono; Merck Sharp & Dohme; Novartis; Pfizer; Roche/Genentech; Sanofi/Regeneron; Summit Therapeutics; Takeda
Research Funding - MSD Oncology
Travel, Accommodations, Expenses - Boehringer Ingelheim; MSD Oncology; Pfizer